Poseidon: Call to Participate in Pre-Commercial Ocean Freight Trials

COVID-19 immunization will need a staggering collaborative effort in intercontinental transportation. Pharmaceutical manufacturers are invited to register their interest in participating in the final Poseidon trials.

Getty Images 1127072463 5e7a15be2627a

The Poseidon Integrated Ocean Freight Program was launched in 2017 to address long-standing quality, safety, and service issues associated with the long-haul transportation of pharmaceutical products.

COVID-19 immunization will require a tremendous drug distribution effort, and Poseidon is gearing up for new trials.

Building on data from its large-scale summer and winter field trials showing the validity of its collaborative ocean-freight model for safe transport of vaccines and drugs, Poseidon is inviting pharmaceutical manufacturers to register their interest in final ocean-freight trials.

As Alan Kennedy, director at Poseidon, says in a post on LinkedIn, “Governments and the pharma industry need to WAKE UP. We need a MULTI-MODAL approach to COVID-19 vaccine transportation. Ahead of us lies nothing less than a mind-boggling logistics challenge, the scale of which, in health industry terms at least, is completely unprecedented. The fact is we need a HIGHLY-CO-ORDINATED, MODALLY INTEGRATED vaccine distribution strategy that takes into account the cost, capacity and sustainability realities of today.”

He highlights the importance of ocean-freight as a sustainable, safe, and efficient mode of inter-continental transportation of bulk temperature-sensitive vaccines.

Pharmaceutical manufacturers are invited to register their interest in participating in the final Poseidon trials here.>>>

More in Cold chain/temperature control